Related Experiment Videos
Pathophysiologic mechanisms of postprandial hyperglycemia.
1Howard Hughes Medical Institute, Chevy Chase, Maryland 20815, USA.
The American Journal of Cardiology
|September 29, 2001
Summary
Postprandial hyperglycemia significantly contributes to diabetes complications. Controlling blood glucose after meals, using medications like alpha-glucosidase inhibitors, is crucial for managing diabetes outcomes.
Area of Science:
- Endocrinology and Metabolism
- Diabetology
- Molecular Medicine
Background:
- Postprandial hyperglycemia, or high blood glucose after meals, plays a larger role in diabetes complications than previously understood.
- Acute glucose spikes trigger detrimental cellular processes, including oxidative stress and advanced glycation end product formation.
- These glucose-mediated tissue defects impact multiple organ systems, affecting both structure and function.
Purpose of the Study:
- To highlight the critical role of postprandial hyperglycemia in the development of diabetes-related complications.
- To emphasize the necessity of controlling both fasting and postprandial plasma glucose for effective diabetes management.
- To advocate for increased focus on monitoring postprandial glycemia for guiding treatment strategies.
Main Methods:
- Review of existing literature on postprandial hyperglycemia and its impact on diabetes complications.
- Discussion of the mechanisms by which acute glucose elevations cause tissue damage.
- Evaluation of therapeutic strategies, specifically alpha-glucosidase inhibitors, for managing postprandial glucose.
Main Results:
- Postprandial hyperglycemia is linked to significant glucose-mediated tissue defects, affecting nearly all organ systems.
- Effective reduction of glycosylated hemoglobin requires control of both fasting and postprandial glucose levels.
- Alpha-glucosidase inhibitors demonstrate efficacy in mitigating postprandial glucose surges by delaying carbohydrate absorption.
Conclusions:
- Controlling postprandial hyperglycemia is essential for preventing or delaying diabetes-related complications.
- Alpha-glucosidase inhibitors offer a valuable therapeutic option for managing postprandial glucose spikes.
- Accurate measurement and clinical utilization of postprandial glycemia data are vital for optimizing diabetes treatment.